Status
Conditions
Study type
Funder types
Identifiers
About
ECMO has improved the outcome of heart or respiratory failure and carcinogenic shock and are increasingly used. However bleeding complications occurring in up to 50% of patients are poorly understood and worsen the overall results. The aim is to investigate the occurence of bleeding and its frequency according to the type of ECMO either veno-arterial or veno-venous. The investigators also want to assess the relation of bleeding with von Willebrand Factor defects.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Sophie SUSEN, MD,PhD; Antoine RAUCH, MD,PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal